Zarxio
Active Ingredient(s): Filgrastim-sndzFDA Approved: * March 6, 2015
Pharm Company: * SANDOZ INC
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Zarxio Overview
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low blood neutrophils.[1] Low neutrophils may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause.[1] It may also be used to increase white blood cells for gathering during leukapheresis.[1] It is given either by injection into a vein or under the skin.[1] Common side effects include fever, cough, c...
Read more Zarxio DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Filgrastim
Recent Zarxio Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Filgrastim-sndz
- Injection: 300 Mcg/0.5 Ml, 300mcg/0.5ml, 300mcg/ml, 480 Mcg/0.8 Ml, 480mcg/0.8ml, 480mcg/1.6ml
- Syringe: 300mgc/0.5ml, 300ug/0.5ml, 480, 480mcg/0.8ml
- Vial: 300mcg/1ml, 300ug/ml, 480, 480mcg/1.6ml
NDC Database Records for Zarxio: (4 results)
Sorted by National Drug Code- 61314-304 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
- 61314-312 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
- 61314-318 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
- 61314-326 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
Other drugs which contain Filgrastim-sndz or a similar ingredient: (3 results)
- FILGRASTIM, G-CSF
- FILGRASTIM-SNDZ
- NEUPOGEN Filgrastim, G-CSF1 discussion